Hill-Rom has signed a definitive agreement to acquire Mortara Instrument Inc for an estimated $330 million, according to the company. Mortara specializes in patient monitoring technology.
Integration of Mortara’s portfolio is expected to expand and enhance Hill-Rom’s offerings in the diagnostic cardiology and vital sign monitoring markets, as well as accelerate growth for Mortara technology on a global scale.
Hill-Rom completed a $2.05 billion deal to acquire Welch Allyn in 2015, expanding its product offerings beyond hospital beds, patient lifting systems, and surgical equipment, and into point-of-care diagnostics and patient monitoring equipment. At the time, Hill-Rom’s product offerings were represented in a hospital’s long-term capital investment cycle. The shorter life cycle of Welch Allyn’s products offered a more steady revenue source for Hill-Rom, and the integration of the two portfolios complemented a healthcare system that was becoming integrated across the continuum of patient care.
